Table 2.
Outcome measures assessed pre- and post-participation in the walking intervention (n = 17)
| Outcome | Baseline | Follow-up | |
|---|---|---|---|
|
Median (min, max) |
Median (min, max) |
P-valuea | |
| Physical functioningb | 332 (266, 356) | 395 (356, 460)* | 0.01 |
| Anxiety | 4 (1, 15) | 4 (0, 16) | 0.63 |
| Depression | 3 (0, 16) | 4 (0, 13) | 0.16 |
| Physical symptoms | 1.06 (0.0, 2.33) | 0.60 (0.06, 2.06)* | 0.14 |
| Quality of lifec (FACT-O) | 109 (72, 146) | 113 (67, 148) | 0.10 |
| Physical wellbeing | 18 (12, 27) | 23 (12.0, 28)* | 0.08 |
| Social wellbeing | 23 (12, 28) | 22 (8, 28) | 0.11 |
| Emotional wellbeing | 20 (7, 24) | 21 (10, 24) | 0.29 |
| Functional wellbeing | 19 (7, 28) | 19 (7, 28) | 0.02 |
| Ovarian-specific concerns | 31 (20, 41) | 36 (21, 44)* | 0.04 |
Clinically meaningful change;*
Wilcoxon signed ranked test used for analysis;a
Physical functioning is measured in metres (m)
Physical functioning data not collected for seven regional women due to inaccessibility;b
A higher score indicates a better quality of life;c
Functional Assessment of Cancer Therapy-Ovary; FACT-O